Foghorn Therapeutics Inc. financial data

Symbol
FHTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
500 Technology Square, Suite 700, Cambridge, MA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 472 % -21.6%
Debt-to-equity -580 % +82.1%
Return On Equity 140 % -84.8%
Return On Assets -29.2 % +1.12%
Operating Margin -277 % +52.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 55.3M shares +32.2%
Common Stock, Shares, Outstanding 55.3M shares +32.2%
Entity Public Float 200M USD -40.4%
Common Stock, Value, Issued 6K USD +50%
Weighted Average Number of Shares Outstanding, Basic 51.6M shares +23.3%
Weighted Average Number of Shares Outstanding, Diluted 51.6M shares +23.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 35.2M USD +61.9%
Research and Development Expense 99.8M USD -12.8%
General and Administrative Expense 30.4M USD -7.62%
Operating Income (Loss) -97.4M USD +22.4%
Nonoperating Income (Expense) 13.6M USD +10.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -83.7M USD +26%
Income Tax Expense (Benefit) 2.72M USD +81.4%
Net Income (Loss) Attributable to Parent -86.4M USD +24.6%
Earnings Per Share, Basic -1.95 USD/shares +28.8%
Earnings Per Share, Diluted -1.95 USD/shares +28.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 139M USD +141%
Assets, Current 290M USD -0.3%
Operating Lease, Right-of-Use Asset 25.5M USD -19.3%
Other Assets, Noncurrent 1M USD -14.7%
Assets 329M USD -3.24%
Accounts Payable, Current 4.81M USD -30.6%
Employee-related Liabilities, Current 2.58M USD -22.5%
Accrued Liabilities, Current 6.45M USD -20.7%
Contract with Customer, Liability, Current 31.2M USD -7.86%
Liabilities, Current 50.9M USD -10.2%
Contract with Customer, Liability, Noncurrent 259M USD -11.1%
Operating Lease, Liability, Noncurrent 32.5M USD -19.2%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 343M USD -11.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -338K USD +87.6%
Retained Earnings (Accumulated Deficit) -520M USD -20%
Stockholders' Equity Attributable to Parent -14.3M USD +71%
Liabilities and Equity 329M USD -3.24%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -29.3M USD +5.89%
Net Cash Provided by (Used in) Financing Activities 1.17M USD +1044%
Net Cash Provided by (Used in) Investing Activities 27.1M USD -8.17%
Common Stock, Shares Authorized 175M shares 0%
Common Stock, Shares, Issued 55.3M shares +32.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.08M USD +31.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 141M USD +137%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 143M USD +27.8%
Deferred Tax Assets, Gross 154M USD +23.7%
Operating Lease, Liability 45.1M USD -12.5%
Payments to Acquire Property, Plant, and Equipment 101K USD -84.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -84.1M USD +26.4%
Lessee, Operating Lease, Liability, to be Paid 51.1M USD -17.2%
Operating Lease, Liability, Current 8.38M USD +9.19%
Lessee, Operating Lease, Liability, to be Paid, Year Two 10.7M USD +1.82%
Lessee, Operating Lease, Liability, to be Paid, Year One 10.7M USD +7.43%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.07M USD -31.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 10.6M USD -0.58%
Deferred Tax Assets, Operating Loss Carryforwards 631K USD -98.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 10.9M USD -0.5%
Additional Paid in Capital 506M USD +30.8%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 3.43M USD +1.72%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 426K USD -76.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%